yeah, my initial reaction when i saw the announcement was that it was positive. But if aggitation fails they were looking at going back to being a pre-clinical company.I think this just buys them some time.
My (baseless) opinion is that they are still in a terrible position.
Ann: BNC105 Clinical Trial In Combination With Nivolumab, page-9
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
